226 related articles for article (PubMed ID: 36576700)
1. H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
Cell Oncol (Dordr); 2023 Apr; 46(2):375-390. PubMed ID: 36576700
[TBL] [Abstract][Full Text] [Related]
2. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
[TBL] [Abstract][Full Text] [Related]
3. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1.
Zhang E; He X; Zhang C; Su J; Lu X; Si X; Chen J; Yin D; Han L; De W
Genome Biol; 2018 Oct; 19(1):154. PubMed ID: 30286788
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
5. Correction to: H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
Cell Oncol (Dordr); 2023 Jun; 46(3):799. PubMed ID: 36645549
[No Abstract] [Full Text] [Related]
6. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
[TBL] [Abstract][Full Text] [Related]
7. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
8. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
10. The binding of lncRNA RP11-732M18.3 with 14-3-3 β/α accelerates p21 degradation and promotes glioma growth.
Kang CM; Bai HL; Li XH; Huang RY; Zhao JJ; Dai XY; Zheng L; Qiu YR; Hu YW; Wang Q
EBioMedicine; 2019 Jul; 45():58-69. PubMed ID: 31202814
[TBL] [Abstract][Full Text] [Related]
11. LncRNA RP11-214F16.8 drives breast cancer tumorigenesis via a post-translational repression on NISCH expression.
Lv X; Zhang Q
Cell Signal; 2022 Apr; 92():110271. PubMed ID: 35108640
[TBL] [Abstract][Full Text] [Related]
12. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
[TBL] [Abstract][Full Text] [Related]
13. A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer.
Kong X; Li J; Li Y; Duan W; Qi Q; Wang T; Yang Q; Du L; Mao H; Wang C
Cell Death Dis; 2021 Jul; 12(7):670. PubMed ID: 34218256
[TBL] [Abstract][Full Text] [Related]
14. A novel hypoxia-stimulated lncRNA HIF1A-AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription.
Xie W; Wang W; Meng S; Wu X; Liu X; Liu Y; Kang X; Su Y; Lv X; Guo L; Wang C
Mol Carcinog; 2023 Dec; 62(12):1860-1876. PubMed ID: 37589417
[TBL] [Abstract][Full Text] [Related]
15. Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.
Chen H; Zheng J; Yan L; Zhou X; Jiang P; Yan F
J Clin Lab Anal; 2021 Jun; 35(6):e23780. PubMed ID: 33942366
[TBL] [Abstract][Full Text] [Related]
16. Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer.
Lu X; Wang J; Wang W; Lu C; Qu T; He X; Liu X; Guo R; Zhang E
Oncogene; 2022 Jun; 41(23):3222-3238. PubMed ID: 35508543
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA RP11-70C1.3 confers chemoresistance of breast cancer cells through miR-6736-3p/NRP-1 axis.
Zhang L; Zheng X; Shen A; Hua D; Zhu P; Li C; Han Z
Bosn J Basic Med Sci; 2022 Feb; 22(1):87-99. PubMed ID: 34374639
[TBL] [Abstract][Full Text] [Related]
18. RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis.
Liu C; Shi J; Jiang Z; Jiang S; Wu Y; Peng D; Tang J; Guo L
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):44-53. PubMed ID: 37905340
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CASC9 activated by STAT3 promotes the invasion of breast cancer and the formation of lymphatic vessels by enhancing H3K27ac-activated SOX4.
Fan SJ; Cui Y; Li YH; Xu JC; Shen YY; Huang H; Hu ZC
Kaohsiung J Med Sci; 2022 Sep; 38(9):848-857. PubMed ID: 35860965
[TBL] [Abstract][Full Text] [Related]
20. LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-Like polarization of tumor-associated macrophages of CPEB4.
Yang D; Liu K; Fan L; Liang W; Xu T; Jiang W; Lu H; Jiang J; Wang C; Li G; Zhang X
Cancer Lett; 2020 Mar; 473():33-49. PubMed ID: 31904478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]